Increased Medicaid Rebates Will Not Significantly Change Generic Manufacturer Participation, CBO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The overall size of the Medicaid program will spur continued participation, according to the Congressional Budget Office.
You may also be interested in...
Senate Finance Committee Approves Increased Generic Manufacturer Rebates
The Medicaid reform provision was marked up within budget reconciliation legislation that otherwise remained unchanged.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: